mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
VER-155008 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
Erlotinib |
UHNBreast |
pan-cancer |
AAC |
0.43 |
0.1 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.1 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.1 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.1 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.046 |
0.2 |